Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Columbia University Hospital Extends Clinical Partnership with RaySearch

Published: Friday, December 20, 2013
Last Updated: Friday, December 20, 2013
Bookmark and Share
The Radiation Therapy Department at Columbia University Hospital has added several RayStation® licenses and the required hardware to support a distributed network environment and adaptive radiation therapy on their Varian and Siemens linear accelerators.

The combined technologies of deformable registration, dose accumulation and adaptive therapy are now available to the planning team which will allow them to commence using advanced planning solutions that focus on treating cancer in a more dynamic way.

Hansen Chen, Director of Technology Development and Systems Integration will be working towards an early 2014 implementation of adaptive therapy, using RayStation® to examine the progress of prescribed treatments over time, correcting delivery as needed to assure that the treatment as originally planned is successfully completed. Hansen Chen comments: “We need efficient tools like RayStation® to help us with the clinical workflow when it comes to technologies like adaptive therapy. To actually apply this type of treatment monitoring and correction takes a great deal of effort and resource planning. If done correctly, we can improve patient care without losing efficiency or increasing costs.”

“We are looking forward to working with Hansen and his organization in advancing these technologies. It is important for us to have customers who want to apply the most advanced planning techniques in their clinics. This helps everyone because their input and practical application helps us make our solutions even better”, says Marc Mlyn, President of RaySearch Americas.

Johan Löf, CEO of RaySearch, adds: “We see adaptive therapy as the next big step in radiation therapy and have worked very hard for several years to create a state-of the-art treatment planning solution with full support for adaptive therapy. The clinical implementation at Columbia is an important step in the development of this new field that will grow in importance immensely over the next few years.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Head Injury Patients Develop Brain Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
New Way to Identify Brain Tumor Aggressiveness
Looking at a brain tumor’s epigenetic signature may help guide therapy.
OncoCyte, The Wistar Institute Enter Global Licensing Agreement
Exclusive rights to commercialize biomarker assay follows years of positive collaboration on lung cancer diagnostic test.
Easier Diagnosis for Fungal Infection of the Lungs
A new clinical imaging method developed in collaboration with a University of Exeter academic may enable doctors to tackle one of the main killers of patients with weakened immune systems sooner and more effectively.
Antibiotic Susceptibility Testing
A team of biologists and biomedical researchers at UC San Diego has developed a new method to determine if bacteria are susceptible to antibiotics within a few hours, an advance that could slow the appearance of drug resistance and allow doctors to more rapidly identify the appropriate treatment for patients with life threatening bacterial infections.
Mitochondrial Troublemakers Unmasked in Lupus
Drivers of autoimmune disease inflammation discovered in the traps of pathogen-capturing white blood cells.
DNA Analysis in the Fast Lane
Rice bioengineers' method should lead to better database of thermal behaviors.
‘Simple Rules’ Calculate Ovarian Cancer Risk
Scientists have formulated a system that uses ultrasound images to accurately work out the likelihood of an ovarian growth being cancerous.
Finding the Needle in a Microbial Haystack
After developing a novel investigational technology called PathoChip that can rapidly identify elusive microorganisms, a team of Penn Medicine researchers recently succeeded for the first time in identifying a pathogen in a patient sample, demonstrating the proof of principle that this technology can be used to identify pathogens in human disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!